Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

Reconsidering the Diagnosis and Management of Obinutuzumab-induced Acute Thrombocytopenia

  • Shinya Fujita
Read full textDOICite

Related

  1. Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer : Insights and outcomes
    Changjian Wang, Chuangyan Wu, Geng Wang +6
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. [Clinical characteristics of acute thrombocytopenia in newly diagnosed follicular lymphoma patients receiving obinutuzumab chemotherapy].
    J X Zhou, L Gao, Y Xia +6
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhiPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. False-negative immunoassays in Heparin Induced Thrombocytopenia
    Aidan Murray, Grace Lee, Ian Welsby +1
    Journal of thrombosis and haemostasis : JTHPeer-reviewedLicence not statedFull textSurgery & anaesthesiaPMC
  4. Predominance of autoimmune heparin-induced thrombocytopenia in a nephrology department
    Manuel Laslandes, Claire Leman, Charles Ronsin +5
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaHAL
  5. Rituximab-induced Acute Thrombocytopenia in Systemic Sclerosis: A Case Report of Two Cases
    Chihiro Saiki, Masahiro Ayano, Yuki Kojima +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{fujita2026reconsidering,
  title = {{Reconsidering the Diagnosis and Management of Obinutuzumab-induced Acute Thrombocytopenia}},
  author = {Shinya Fujita},
  journal = {Internal Medicine},
  year = {2026},
  month = aug,
  doi = {10.2169/internalmedicine.6780-25},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/16/65_6780-25/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Reconsidering the Diagnosis and Management of Obinutuzumab-induced Acute Thrombocytopenia
AU  - Shinya Fujita
PY  - 2026
DA  - 2026/08/15
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.6780-25
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/65/16/65_6780-25/_article
SN  - 1349-7235
SN  - 0918-2918
ER  -